IPO News

The IPO market is showing strong signs of a rebound in mid-2025, fueled by improving economic stability and renewed investor confidence. After a period of caution, a solid pipeline of companies, particularly in the technology and life sciences sectors, is now emerging. High-profile debuts have performed well, encouraging other unicorns to accelerate their listing plans. While market volatility remains a consideration, the overall sentiment is optimistic for a more active and receptive second half.

Global IPO markets are active, with strong showings in the Middle East as Saudi airline flynas and healthcare firm SMC launch successful offerings. The Asia-Pacific region is also bustling with major listings in the Philippines and Australia, while Hong Kong's market rebounds. In contrast, London faces setbacks as fintech Wise shifts its primary listing to the U.S. and Cobalt Holdings cancels its float, even as U.S. crypto and aerospace firms successfully go public.

Global IPO activity remains dynamic. The U.S. sees Netskope targeting a $5B+ IPO valuation and Omada Health raising $158M. Europe anticipates a potential £4.5B Automobile Association deal and Cobalt Holdings' $230M IPO. In Asia-Pacific, Shein considers a Hong Kong listing, Sony plans a major financial arm spin-off, and 'Baby Shark' creator Pinkfong files its IPO, showcasing diverse market movements across key financial hubs.

Global IPO markets exhibit robust activity across regions. MENA sees significant listings like Flynas raising $1.1B and Dubai Residential REIT's $584M debut. In the U.S., Circle targets a $5B+ IPO valuation, alongside Medtronic's diabetes unit spin-off and Voyager's NYSE filing. Asia-Pacific highlights Maynilad's $820M IPO and new Chinese regulations for overseas listings, while Europe shows activity with Cobalt Holdings and a potential Sentia IPO, signaling broad market momentum.

Global IPO activity is buzzing, with significant movements across regions. In the U.S., tech firms like Figma are gearing up for major listings, while Omada Health has filed. The Asia-Pacific market, particularly Hong Kong, shows renewed vigor with CATL's $4.6 billion deal and substantial offerings from Jiangsu Hengrui and Foshan Haitian. Meanwhile, Dubai Residential REIT's offering in the MENA region saw strong demand, and Europe's Newlat Food is exploring a London IPO.

Global IPO markets show varied activity. In the U.S., travel tech firm Navan is preparing a significant IPO potentially valued over $8 billion, while eToro targets a $4 billion valuation. Asia-Pacific is bustling, highlighted by CATL's $5 billion Hong Kong listing and Chery Automobile's $1.5 billion plan. The MENA region, particularly Saudi Arabia with flynas and strong Q1 results, alongside a new Dubai REIT, displays robust momentum. Europe sees future plans from BASF's agriculture arm.

Market volatility continues to influence global IPO plans. In the U.S., HistoSonics explores a $2.5B+ sale instead of an IPO. Shein weighs U.S. restructuring as tariff risks impact its London IPO ambitions. Asia-Pacific sees mixed activity: CATL launches its major Hong Kong listing and Eco-Shop its Malaysian IPO, but Vietnam's Masan Consumer delayed its IPO and two large Korean listings were pulled. MENA sees potential IPOs from CloudKitchens, iMENA, and Etihad under consideration.

Despite market headwinds, IPO activity persists. Chinese broker Yuanbao launched its $30M US IPO, while Vedanta mulls a potential $1B US listing for its copper assets. Europe sees German firm Pfisterer and Greece's Qualco plan IPOs around €100M each. Asia-Pacific remains active, with Robex launching a ~$77M Australian IPO, multiple Hong Kong listings underway (Breton, Green Tea, Xiao Noodles), Tekscend eyeing Tokyo, and Galaxy targeting a $1B Korean IPO for 2026.

Despite global market volatility delaying IPOs like Ebury's £2bn London plan, activity continues. Figma filed for a US IPO after Adobe's deal failed. Saudi Arabia sees ongoing listings (UCIC, Flynas, Barn's), while South Korea's DN Solutions launched a $1bn+ IPO. China Southern eyes a Hong Kong IPO for its cargo unit, Zhipu AI started its A-share process, Eco-Shop plans its Malaysian IPO, and ABB targets a 2026 robotics spin-off.

Global IPO and M&A markets face significant disruption from U.S. tariffs and trade war fears, causing widespread delays. Companies like Klarna, Chime, eToro, 1komma5, and Nodica have postponed listings, particularly those targeting U.S. exchanges. Volatility also impacted Cuckoo Malaysia's IPO plans. Despite this, Chagee launched its Nasdaq IPO, CATL gained approval for a large Hong Kong listing, Shein secured UK approval, and Virgin Australia targets a June IPO in Sydney.

Global IPO market faces significant headwinds as tariff announcements trigger widespread delays. Key players Klarna, StubHub and eToro have all postponed their public debuts amid market turmoil, with IPOX analyst Lukas Muehlbauer noting that "market instability naturally makes any company hit the brakes on near-term IPO plans."

The global IPO market maintains momentum as diverse offerings advance across regions. eToro leads with a $750M Nasdaq filing after profits soared to $192M, while Chinese tea chain Chagee targets up to $500M for its U.S. debut. Cerebras faces regulatory delays over Abu Dhabi investment ties. In Europe, Volkswagen explores a potential €5B listing for MAN Energy Solutions, while UAE renewable giant Masdar begins evaluating Abu Dhabi and potential New York listings to fund its ambitious 100GW capacity expansion goals.

The IPOX® Update highlights major upcoming public offerings across global markets. Leading the pack is CoreWeave's $2.7B Nasdaq listing alongside significant deals from Klarna ($1B+), Ukraine's Kyivstar ($2.2B), and Hinge Health ($500M). The report covers 13 companies preparing to go public across the U.S., Europe, and Asia-Pacific regions, with detailed insights on valuations, timing, and market challenges.

AI and health tech lead March's IPO surge with CoreWeave securing a $12B OpenAI contract ahead of its New York debut, while Hinge Health files to raise $500M. The pipeline remains robust across regions with StubHub targeting $1B+ in the US, South Korea's DN Solutions seeking $1B in Seoul, and Air Baltic planning a London listing. MENA markets show strength with Umm Al Qura's offering attracting over $1B from retail investors alone, while China's tech sector sees renewed listing momentum.

AI-powered CoreWeave targets $4B raise at $35B valuation, while fintech giant Klarna prepares $1B+ New York debut. Tech dominates upcoming listings with cryptocurrency exchanges Gemini and Kraken, design platform Figma, and communications app Discord all planning 2025 offerings. Europe and Asia-Pacific markets see continued activity with healthcare, finance and industrial firms leading the charge.

Global IPO activity is spread across regions. In the U.S., CoreWeave and Holcim's Amrize are planning major listings. Europe sees Olam Food Ingredients gearing up for a London IPO and Northern Data for Frankfurt uplisting. Asia-Pacific is vibrant with Mixue's Hong Kong IPO seeing huge demand and JX Advanced Metals launching a large Tokyo IPO. Saudi Arabia's Umm Al Qura IPO in MENA was heavily oversubscribed, showcasing diverse IPO opportunities globally.

Global IPO markets are active with diverse listings planned across regions. Hong Kong anticipates large offerings from Kayou ($500M) and Mixue ($443M), while Malaysia's Eco-Shop eyes $212M. Oman's Asyad Shipping targets $333M, and Abu Dhabi's Alpha Data, $163M. Saudi Arabia expects a record IPO year. In the US, Redcloud revives a smaller offering. Europe sees potential listings from Swedish SBB and German OLB, with Shein considering London amidst valuation pressures. Singapore aims to attract Chinese listings.

Global IPO activity is high, especially in the US with Klarna's potential $15B IPO. Asia-Pacific is highlighted by JX Advanced Metal's potential record $3B Japan IPO and Mixue's $500M HK listing. Europe sees Novo Banco's €5B IPO and London vying for listings like IVC Evidensia and CurrentBody.

Robust global IPO activity across multiple sectors: Significant US listings include SailPoint, projecting an $11.5B valuation, and DailyPay, targeting $3-4B. Honeywell's planned spin-offs represent a notable corporate restructuring. European markets are active, featuring Novo Banco and CurrentBody. In Asia, MMC Port's anticipated $1.34B Malaysian IPO highlights the region's strength. The Middle East maintains a positive outlook, with Saudi Arabia driving deal flow.

Large potential IPOs are emerging across regions. In the US, Silvus considers a $5B valuation IPO, while Histosonics aims for a multi-billion dollar valuation. SailPoint eyes a $1B Nasdaq return. Europe sees EcoCeres planning a $5B IPO and HBX Group with strong book coverage for its Amsterdam listing.

US IPO market shows signs of heating up in early 2025 with notable confidential filings like Voyager Technologies in space and defense ($2-3B valuation). Odyssey Therapeutics (biotech), SailPoint (cybersecurity), and Metsera (obesity drugs) have also filed for IPOs on Nasdaq. While January saw a slow start, NYSE anticipates a robust IPO market recovery driven by a strong economy and potentially lower interest rates, suggesting a positive outlook for US listings in the coming months.

U.S. IPO activity is picking up with eToro's potential $5 billion+ and Klarna's possible $20 billion IPO. Titan America aims to raise over $500 million. In Asia, LG CNS priced its IPO at $823 million, and Guming Holdings targets $300 million in Hong Kong. Europe sees HBX Group's €725 million IPO. Riyad Capital's potential $2.5 billion IPO leads activity in MENA.

IPO activity is picking up globally, with the US seeing filings from biotech firms like Maze and Metsera. Europe anticipates large listings from Stada and HBX Group, while Shein and Shawbrook consider London. In Asia, NTT plans a Singapore REIT IPO, and several Chinese firms eye Hong Kong, though CATL's faces US blacklisting concerns. LG CNS launched its IPO in South Korea, while K Bank canceled its attempt. Saudi Tabreed is planning a potential Riyadh IPO.

EG Group, a UK-based fuel station operator, is planning a U.S. IPO valued at over $16 billion. Ascentage Pharma seeks $100 million in a Nasdaq IPO for cancer treatments. Germany's IPO market anticipates growth in 2025 with major listings. Chery Auto aims for a $1 billion Hong Kong IPO, valuing it at $14 billion. Meanwhile, Hong Kong will see 8 IPOs raising $755 million by mid-January 2025, reflecting robust investor interest.

In recent IPO news, the US market sees Databricks potentially delaying its IPO post-funding, while FedEx explores options for its freight division. Shifting focus internationally, there's positive momentum as EV battery giant CATL considers a significant Hong Kong listing. Adding to the upbeat news, Greek multinational METLEN is advancing its multi-billion pound London IPO, showcasing confidence in European markets.

London's IPO market shows mixed signals with French streaming firm Canal+ planning a €5-6 billion listing, while facing challenges with Shein's delayed approval over supply chain concerns. In Asia, Orion Breweries prepares for a $200 million Tokyo listing, Foshan Haitian seeks a HK$1.5 billion Hong Kong dual listing, and Kioxia completed an $800 million IPO, though at a valuation significantly below its 2018 level.

Recent IPO announcements reflect strong global market activity across diverse sectors. Notable listings include Holcim's $30 billion North American spin-off, Seven & i's $6.6 billion 7-Eleven USA IPO, and ServiceTitan's $5.16 billion tech listing in the U.S. The MENA region sees healthcare and retail offerings from Almoosa Health and Nice One, while Asia-Pacific activity includes Kioxia's $727 million Tokyo listing and Mao Geping's $270 million Hong Kong debut.

Global companies are preparing IPOs amid varied market conditions. In the U.S., ServiceTitan and CoreWeave plan significant offerings despite financial pressures. European firms like Apotea, Thyssenkrupp's Marine Systems, Odido, and Cirsa are set for listings. In Asia-Pacific, Insta360 and Mr DIY's Indonesian arm aim to go public. MENA's Talabat plans the UAE's largest IPO. Biotech firms Odyssey and Aktis proceed despite sector uncertainties, and Australia's Anteris files for a U.S. IPO.

Medline Industries plans a $5B U.S. IPO in 2025, potentially valuing the company at $50B. Pony AI seeks $260M in a U.S. IPO with Uber investing $10M. ServiceTitan files for Nasdaq listing, targeting SaaS growth. Canadian retailer Groupe Dynamite raises $300M. In Asia, Kioxia aims for $4.8B valuation, while Talabat targets $1.5B in Dubai. Australian DigiCo REIT launches a $1.8B IPO. UAE’s Pure Harvest eyes IPO by 2028.

Several companies are preparing IPOs globally. Highlights include Klarna's $20B U.S. IPO, Pony AI targeting a $4.48B Nasdaq valuation, and Venture Global LNG raising $3B. In Europe, VEON plans to list Kyivstar, and Carlyle considers a $4B IPO for Flender. Asia sees IPOs from Mokingran Jewellery, Dmall, and Adaro Energy, among others. Meanwhile, Middle Eastern IPOs feature Talabat’s $1B offering and UIHC's $264M debut. Key sectors include fintech, energy, transportation, and tech.